VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRSPrudential Financial, Inc. 5.62
$21.90$7.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRSQuarterly Financials

Prudential Financial, Inc. 5.62 (PRS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Prudential Financial, Inc. 5.62 (PRS) quarterly income statement — complete revenue, gross profit & net income history

PRS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue15.53B15.69B17.89B13.73B13.47B12.52B19.49B14.88B23.51B15.08B8.35B13.5B
Revenue Growth %15.26%25.29%-8.22%-7.77%-42.7%-16.98%133.36%10.26%37.92%26.64%-58.66%18.49%
Medical Costs & Claims08.77B10.13B8.18B8.14B7.63B14.03B8.86B16.59B7.8B5.16B7.66B
Medical Cost Ratio %0%55.9%56.64%59.6%60.43%60.96%71.97%59.56%70.59%51.73%61.82%56.76%
Gross Profit06.92B7.76B5.54B5.33B4.89B5.46B6.02B6.92B7.28B3.19B5.84B
Gross Margin %0%44.1%43.36%40.4%39.57%39.04%28.03%40.44%29.41%48.27%38.18%43.24%
Gross Profit Growth %-100%41.52%41.97%-7.88%-22.92%-32.85%71.31%3.12%2.58%37.46%-21.24%69.98%
Operating Expenses05.71B5.89B4.78B4.38B5B4.87B4.58B5.47B5.6B4.23B5.22B
OpEx / Revenue %0%36.39%32.93%34.85%32.52%39.94%25%30.8%23.29%37.1%50.66%38.66%
Depreciation & Amortization0-49M-144M482M-161M53M-41M-26M397M-71M-45M5M
Combined Ratio %0%92.29%89.57%94.46%92.95%100.9%96.97%90.36%93.87%88.83%112.48%95.41%
Operating Income-2.42M1.21B1.86B761M949M-113M591M1.44B1.44B1.69B-1.04B619M
Operating Margin %-0.02%7.71%10.43%5.54%7.05%-0.9%3.03%9.64%6.13%11.17%-12.48%4.59%
Operating Income Growth %-100.26%1170.8%215.57%-46.97%-34.1%-106.71%156.72%131.83%-22.54%3056.14%-775.63%154.49%
EBITDA-2.42M1.16B1.72B1.24B788M-60M550M1.41B1.84B1.61B-1.09B624M
EBITDA Margin %-0.02%7.4%9.62%9.06%5.85%-0.48%2.82%9.47%7.81%10.7%-13.01%4.62%
Interest Expense000000000442M00
Non-Operating Income000000000-442M00
Pretax Income-2.42M1.21B1.86B761M949M-113M591M1.44B1.44B1.69B-1.04B619M
Pretax Margin %-0.02%7.71%10.43%5.54%7.05%-0.9%3.03%9.64%6.13%11.17%-12.48%4.59%
Income Tax-599.42M269M382M195M207M-186M140M264M289M359M-251M123M
Effective Tax Rate %24769.42%22.23%20.48%25.62%21.81%164.6%23.69%18.4%20.07%21.31%24.09%19.87%
Net Income597M905M1.43B533M707M-57M448M1.2B1.14B1.32B-802M511M
Net Margin %3.85%5.77%8%3.88%5.25%-0.46%2.3%8.05%4.84%8.73%-9.6%3.79%
Net Income Growth %-15.56%1687.72%219.42%-55.51%-37.87%-104.33%155.86%134.44%-22.16%2632.69%-771.74%150.59%
EPS (Diluted)1.712.554.011.481.96-7.651.243.283.123.62-2.231.38
EPS Growth %-12.76%133.33%223.39%-54.88%-37.18%-311.33%155.61%137.68%-20.61%338.16%-757.69%150.74%
EPS (Basic)1.722.564.031.491.97-7.691.243.303.133.62-2.231.38
Diluted Shares Outstanding349.4M350.9M353M354.9M356.1M361.96M358.7M360.5M360.5M361M362.6M366.1M